Summary: Florida House Bill 1617 sets new safety, registration, and consent rules for regenerative clinics across the state. At STEMS Health, these standards have always been core to patient care. This article explains how the clinic already goes beyond what the law requires – prioritizing safety, transparency, and proven science in every treatment.
What House Bill 1617 Requires from Regenerative Clinics
House Bill 1617 is Florida’s legislative answer to a growing problem: unregulated stem cell clinics offering questionable therapies with little oversight. The bill is designed to create accountability and protect patients by enforcing standardized practices across the regenerative medicine field.
The bill has already passed in the Florida Senate, and if passed in the House, HB 1617 will require:
Clinic Registration with the Florida Department of Health. Any clinic offering regenerative treatments – like stem cell, platelet-rich plasma (PRP), or exosome-based procedures – must officially register with the state. This allows for regulatory oversight and verification of legitimacy.
Informed Consent in Writing. Before undergoing any regenerative treatment, patients must receive a detailed written consent form that:
- Explains the risks and benefits
- Clarifies whether the treatment is FDA-approved or investigational
- Lists alternatives to the proposed therapy
Advertising Accountability. Clinics may not advertise treatments as “FDA-approved” or “guaranteed” unless those statements are scientifically and legally accurate. Overhyped or misleading marketing is subject to enforcement under the bill.
State Enforcement Mechanisms. The Florida Department of Health will be able to audit clinics, investigate patient complaints, issue warnings or cease-and-desist orders, and report serious violations for further legal or disciplinary action.
Why This Bill Was Needed
Florida has seen an influx of regenerative medicine clinics – some reputable, many not. Without state-level oversight, some facilities have delivered unproven treatments, used unlicensed personnel, or made bold claims that didn’t match scientific reality. Patients have paid the price – sometimes literally, with thousands spent on ineffective care, and in rare cases, with serious health consequences.
House Bill 1617 is not a ban on stem cell therapy. It’s a framework to ensure that when patients choose regenerative care, they’re getting it from clinics that meet clear ethical and clinical standards.
STEMS Health’s Commitment to Excellence—Before It Was Mandated
At STEMS Health, led by Dr. Ankeet Choxi and Dr. Jarred Mait, the standards laid out in HB 1617 aren’t a future goal – they’re current practice. Here’s how STEMS Health already aligns with, and often exceeds, the bill’s requirements:
Registered, Licensed, and Credentialed Providers. Every treatment is delivered by experienced, board-certified physicians who specialize in regenerative medicine. No corners are cut when it comes to professional qualifications.
Transparent, Written Informed Consent. Patients at STEMS Health receive clear, documented explanations of what a treatment is, whether it’s FDA-approved or investigational, and what results can reasonably be expected. There is no guesswork.
Evidence-Based Therapies Only. We only offer treatments backed by peer-reviewed research or recognized within FDA-compliant guidelines. Popular but unproven biologics – like certain exosome therapies without IND approvals – are not administered.
Ethical Communication and Patient Education. There are no exaggerated claims. No miracle cures. Just honest, informed conversations about what regenerative medicine can and cannot do. Education is part of the treatment plan.
Going Beyond the Basics: What Sets STEMS Health Apart
While many clinics may scramble to meet HB 1617’s standards, STEMS Health is already leading. Here’s what else we offer:
Personalized Regenerative Protocols. Treatments are not “one-size-fits-all.” Each patient receives care tailored to their medical history, goals, and condition.
Advanced Follow-Up and Monitoring. Patients are tracked through post-treatment check-ins and outcome assessments to ensure long-term benefit and safety.
Multidisciplinary Integration. Regenerative therapies are often paired with functional medicine, nutrition, and lifestyle guidance – maximizing recovery and performance.
Patient Advocacy and Trust. If a treatment isn’t right for you, the doctors will tell you. If a referral to another specialist is better, they’ll make it. Your outcome, not a sale, is the clinic’s top priority.
For Patients, HB 1617 Is Reassurance – Not a Restriction
As a patient, you deserve to know that your clinic is safe, your treatment is backed by science, and your care team is accountable. That’s what House Bill 1617 provides.
At STEMS Health, it’s what you already receive – no legislation required.
More About STEMS Health Miami Beach
Our double-board certified physicians are here to answer your questions and tailor stem cell treatments specifically for your long-term health goals. STEMS also provides stem cell therapies for a range of conditions, including hair loss, stem cell facials, tennis injuries, golf related injuries, jaw disorders, and other regenerative treatments, for patients in the Miami Beach area.
FAQs Florida Stem Cell Therapy HB 1617
Will I need to change clinics if HB 1617 becomes law?
Only if your current clinic isn’t registered or compliant. STEMS Health is already aligned with the law’s requirements, so no change is necessary.
Does the bill affect the treatments available at STEMS Health?
No. STEMS Health already offers therapies that are FDA-compliant or clearly disclosed as investigational. Nothing will need to change if the bill passes.
How do I know if a clinic is registered under HB 1617?
Ask if the clinic is registered with the Florida Department of Health and request documentation during your consultation.
What makes STEMS Health different from other providers?
STEMS Health prioritizes medical integrity, patient education, and clinical transparency—well beyond what’s legally required. You’re treated as a partner, not a customer.
